Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2012 1
2013 1
2014 4
2015 3
2016 4
2017 8
2018 4
2019 6
2020 3
2021 5
2022 4
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
Polyoxazoline-Based Nanovaccine Synergizes with Tumor-Associated Macrophage Targeting and Anti-PD-1 Immunotherapy against Solid Tumors.
Matos AI, Peres C, Carreira B, Moura LIF, Acúrcio RC, Vogel T, Wegener E, Ribeiro F, Afonso MB, Santos FMF, Martínez-Barriocanal Á, Arango D, Viana AS, Góis PMP, Silva LC, Rodrigues CMP, Graca L, Jordan R, Satchi-Fainaro R, Florindo HF. Matos AI, et al. Among authors: florindo hf. Adv Sci (Weinh). 2023 Sep;10(25):e2300299. doi: 10.1002/advs.202300299. Epub 2023 Jul 11. Adv Sci (Weinh). 2023. PMID: 37434063 Free PMC article.
Editorial: Highlights in nano-based drug delivery 2021/22.
Kumar S, Florindo HF, Pasut G. Kumar S, et al. Among authors: florindo hf. Front Med Technol. 2023 Feb 24;5:1130414. doi: 10.3389/fmedt.2023.1130414. eCollection 2023. Front Med Technol. 2023. PMID: 36908293 Free PMC article. No abstract available.
MCP-1/CCR2 axis inhibition sensitizes the brain microenvironment against melanoma brain metastasis progression.
Pozzi S, Scomparin A, Ben-Shushan D, Yeini E, Ofek P, Nahmad AD, Soffer S, Ionescu A, Ruggiero A, Barzel A, Brem H, Hyde TM, Barshack I, Sinha S, Ruppin E, Weiss T, Madi A, Perlson E, Slutsky I, Florindo HF, Satchi-Fainaro R. Pozzi S, et al. Among authors: florindo hf. JCI Insight. 2022 Sep 8;7(17):e154804. doi: 10.1172/jci.insight.154804. JCI Insight. 2022. PMID: 35980743 Free PMC article.
Therapeutic targeting of PD-1/PD-L1 blockade by novel small-molecule inhibitors recruits cytotoxic T cells into solid tumor microenvironment.
Acúrcio RC, Pozzi S, Carreira B, Pojo M, Gómez-Cebrián N, Casimiro S, Fernandes A, Barateiro A, Farricha V, Brito J, Leandro AP, Salvador JAR, Graça L, Puchades-Carrasco L, Costa L, Satchi-Fainaro R, Guedes RC, Florindo HF. Acúrcio RC, et al. Among authors: florindo hf. J Immunother Cancer. 2022 Jul;10(7):e004695. doi: 10.1136/jitc-2022-004695. J Immunother Cancer. 2022. PMID: 35863821 Free PMC article.
Current hurdles to the translation of nanomedicines from bench to the clinic.
Đorđević S, Gonzalez MM, Conejos-Sánchez I, Carreira B, Pozzi S, Acúrcio RC, Satchi-Fainaro R, Florindo HF, Vicent MJ. Đorđević S, et al. Among authors: florindo hf. Drug Deliv Transl Res. 2022 Mar;12(3):500-525. doi: 10.1007/s13346-021-01024-2. Epub 2021 Jul 23. Drug Deliv Transl Res. 2022. PMID: 34302274 Free PMC article. Review.
Preclinical models and technologies to advance nanovaccine development.
Peres C, Matos AI, Moura LIF, Acúrcio RC, Carreira B, Pozzi S, Vaskovich-Koubi D, Kleiner R, Satchi-Fainaro R, Florindo HF. Peres C, et al. Among authors: florindo hf. Adv Drug Deliv Rev. 2021 May;172:148-182. doi: 10.1016/j.addr.2021.03.001. Epub 2021 Mar 9. Adv Drug Deliv Rev. 2021. PMID: 33711401 Review.
42 results